학술논문
Proposed Biosimilar Gan & Lee Insulin Aspart (GL-ASP) Shows Pharmacokinetic (PK) and Pharmacodynamic (PD) Bioequivalence (BE) to US- and EU-Licensed Insulin Aspart (ASP)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
1939327X